Table 2.
Cell line | ATCC # | Growth medium | Supplements |
---|---|---|---|
NIH3T3 | CRL-1658 | DMEM | 10 % FBS |
L929 | CCL-1 | EMEM | 10 % FBS |
MC3T3-E1, subclone 4 | CRL-2593 | MEM | 10 % FBS |
RAW 264.7 | TIB-71 | DMEM | 10 % FBS |
M. dunni | CRL-2017 | McCoy’s 5A | 10 % FBS |
P3X63Ag8.653 | CRL-1580 | RPMI-1640 | 10 % FBS |
HK-PEG-1 | CCL-189 | IMDM | 20 % FBS |
Vero | CCL-81 | MEM- α | 10 % FBS |
COS-7 | CRL-1651 | DMEM | 10 % FBS |
HEPM | CRL-1486 | EMEM | 10 % FBS |
SK-BR-3 | HTB-30 | McCoy’s 5A | 10 % FBS |
MCF 10A | CRL-10317 | MECGM | 0.4 % bovine pituitary extract, 0.5 μg/mL hydrocortisone, 3 ng/mL human epidermal growth factor, 5 μg/mL insulin |
HeLa | CCL-2 | EMEM | 10 % FBS |
CHO-K1 | CCL-61 | F-12 K | 10 % FBS |
Dulbecco’s Modified Eagle’s Medium (DMEM) (ATCC), Eagle’s Minimum Essential Medium (EMEM) (ATCC), Minimum Essential Medium (MEM) (Gibco, Carlsbad, CA, USA), Iscove’s Modified Dulbecco’s Medium (IMDM) (ATCC), MEM- α (Invitrogen, Carslbad, CA, USA), RPMI-1640 (ATCC), McCoy’s 5A (ATCC), F-12 K Medium (ATCC), Mammary Epithelial Cell Growth Medium (MECGM) and associated supplements (Lonza, Rockland, ME, USA), fetal bovine serum (FBS) (Invitrogen)